trending Market Intelligence /marketintelligence/en/news-insights/trending/pe7kfxj72wsit7-wp9afyg2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Benitec Biopharma, NantWorks to collaborate on cancer program

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Benitec Biopharma, NantWorks to collaborate on cancer program

Benitec Biopharma Ltd. is in talks for a sub-license from Patrick Soon-Shiong's NantWorks to develop treatments for head and neck cancer using a gene silencing approach.

The company is negotiating terms of the collaboration with a targeted date for execution of Jan. 27, 2017.